Programmed Death 1 Ligand Expression in the Monocytes of Patients with Hepatocellular Carcinoma Depends on Tumor Progression.
CD14+ cells
hepatocellular carcinoma
programmed death 1 ligands
Journal
Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829
Informations de publication
Date de publication:
14 Aug 2020
14 Aug 2020
Historique:
received:
28
06
2020
revised:
05
08
2020
accepted:
08
08
2020
entrez:
23
8
2020
pubmed:
23
8
2020
medline:
23
8
2020
Statut:
epublish
Résumé
Monocytes (CD14
Identifiants
pubmed: 32824016
pii: cancers12082286
doi: 10.3390/cancers12082286
pmc: PMC7465257
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : Japan Society for the Promotion of Science
ID : 18K08018, 18KK0456, 19K08942
Références
Cell. 2015 Jan 15;160(1-2):48-61
pubmed: 25594174
Front Immunol. 2020 Jul 07;11:1508
pubmed: 32733486
J Leukoc Biol. 2012 Oct;92(4):859-67
pubmed: 22730547
Nat Rev Clin Oncol. 2019 Sep;16(9):563-580
pubmed: 31092901
J Leukoc Biol. 2019 Aug;106(2):345-358
pubmed: 30576000
PLoS One. 2012;7(6):e39294
pubmed: 22723990
Liver Cancer. 2012 Nov;1(3-4):144-58
pubmed: 24159579
Int J Cancer. 2017 Jan 15;140(2):370-380
pubmed: 27685836
Nature. 2016 Sep 15;537(7620):417-421
pubmed: 27501248
Hepatology. 2011 Mar;53(3):1020-2
pubmed: 21374666
Nature. 2016 May 23;534(7607):402-6
pubmed: 27281199
Cancer Discov. 2013 Dec;3(12):1355-63
pubmed: 24078774
Oncogene. 2020 Apr;39(18):3620-3637
pubmed: 32157213
J Immunol. 2010 Aug 15;185(4):2044-50
pubmed: 20660352
Oncoimmunology. 2017 Mar 3;6(4):e1299301
pubmed: 28507807
Science. 2016 Jul 22;353(6297):399-403
pubmed: 27463676
Int J Cancer. 2008 Nov 1;123(9):2222-7
pubmed: 18688847
Cancers (Basel). 2019 Oct 14;11(10):
pubmed: 31615069
J Leukoc Biol. 2006 Dec;80(6):1298-307
pubmed: 16905575
Nat Immunol. 2006 Mar;7(3):311-7
pubmed: 16462739
Cancer Res. 2016 Jan 15;76(2):227-38
pubmed: 26637667
Nat Rev Immunol. 2011 Oct 10;11(11):762-74
pubmed: 21984070
Cancer Cell Int. 2019 Jan 29;19:22
pubmed: 30718977
Sci Rep. 2020 Jun 25;10(1):10377
pubmed: 32587357
Lancet. 2017 Jun 24;389(10088):2492-2502
pubmed: 28434648
Proc Natl Acad Sci U S A. 2002 Sep 17;99(19):12293-7
pubmed: 12218188
J Immunol. 2015 Dec 1;195(11):5169-77
pubmed: 26525287
Clin Cancer Res. 2013 Jul 1;19(13):3404-15
pubmed: 23653148
Immunity. 2018 Mar 20;48(3):434-452
pubmed: 29562194
Am J Pathol. 2015 Feb;185(2):420-31
pubmed: 25485859
J Immunol. 2005 May 15;174(10):6477-89
pubmed: 15879151
Cytokine. 2015 May;73(1):8-15
pubmed: 25689617
Front Immunol. 2019 Jul 16;10:1643
pubmed: 31379842
Cancer Sci. 2016 Nov;107(11):1696-1704
pubmed: 27564404
Nat Rev Immunol. 2007 Mar;7(3):238-43
pubmed: 17290299
Mayo Clin Proc. 2015 Jun;90(6):756-64
pubmed: 26046410
Leukemia. 2020 Sep;34(9):2405-2417
pubmed: 32089543
J Leukoc Biol. 2009 Nov;86(5):1065-73
pubmed: 19741157
N Engl J Med. 2019 Apr 11;380(15):1450-1462
pubmed: 30970190
Trends Immunol. 2004 Dec;25(12):677-86
pubmed: 15530839
Eur J Cancer. 2015 Feb;51(3):421-6
pubmed: 25582496
Science. 2016 Apr 8;352(6282):227-31
pubmed: 26966191
Blood. 2011 Nov 24;118(22):5938-46
pubmed: 21926352
J Leukoc Biol. 2019 Aug;106(2):309-322
pubmed: 30776148
Mol Cancer Ther. 2015 Apr;14(4):847-56
pubmed: 25695955
Cancer Microenviron. 2013 Aug;6(2):179-91
pubmed: 23179263
Nat Rev Gastroenterol Hepatol. 2019 Oct;16(10):589-604
pubmed: 31439937
BMJ. 2018 Sep 10;362:k3529
pubmed: 30201790
J Exp Med. 2016 Dec 12;213(13):2835-2840
pubmed: 27903604
N Engl J Med. 2015 Jan 22;372(4):311-9
pubmed: 25482239
Lancet. 2017 Dec 2;390(10111):2461-2471
pubmed: 28993052
J Immunol. 2009 Jun 1;182(11):6682-9
pubmed: 19454662